SCHEMBL19859915

SCHEMBL19859915

NCc1ccc(C(=O)C(O)c2ccccc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.67
CES2 O00748 3/20 0.67
CES1 P23141 3/20 0.67
KDM4E B2RXH2 1/20 0.57
ALDH1A1 P00352 1/20 0.57
MAPK1 P28482 1/20 0.47
HDAC3 O15379 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
NCOR2 Q9Y618 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
LOXL2 Q9Y4K0 3/20 0.43
TAAR1 Q96RJ0 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42
HSD17B10 Q99714 1/20 0.41
MDM2 Q00987 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19859914 0.93 CES2 (0.67) LMNACES2CES1KDM4EALDH1A1
SCHEMBL28291616 0.91 CES2 (0.53) LMNACES2CES1KDM4EALDH1A1
SCHEMBL11117722 0.84 LMNA (0.69) LMNACES2CES1KDM4EALDH1A1
SCHEMBL27608906 0.83 CES2 (0.46) LMNACES2CES1KDM4EALDH1A1
SCHEMBL18096456 0.83 CES2 (0.67) LMNACES2CES1KDM4EALDH1A1
SCHEMBL1788851 0.83 LMNA (0.67) LMNACES2CES1KDM4EALDH1A1
Benzoin SCHEMBL2025536 0.81 CES2 (1.00) LMNACES2CES1KDM4EALDH1A1
Benzoin SCHEMBL10665271 0.81 CES2 (1.00) LMNACES2CES1KDM4EALDH1A1
Benzoin SCHEMBL145 0.81 CES2 (1.00) LMNACES2CES1KDM4EALDH1A1
Benzoin SCHEMBL5833429 0.81 CES2 (1.00) LMNACES2CES1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3497108-A1 CHELATED PSMA INHIBITORS Cancer Targeted Technology LLC (US) 2019-06-19 EP disclosed
WO-2018031809-A1 CHELATED PSMA INHIBITORS CANCER TARGETED TECHNOLOGY LLC (US) 2018-02-15 WO disclosed